Skip to main content
OpenTrials
Completed

NCT Number: NCT00828555

Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting

PURPOSE To develop, implement, and evaluate the effectiveness of a program designed to assist community Ob/Gyns in vaccinating adolescent and adult women against vaccine-preventable diseases.

SPECIFIC AIMS

1. Determine the feasibility of implementing a successful vaccination program for adolescent and adult women in Ob/Gyn offices by direct assessment of medical personnel & office staff on their:

* Attitudes towards vaccination of women against preventable diseases * Perceived barriers to implementing a program to vaccinate women in their offices * Ideas on how to overcome barriers to successful program implementation * Current vaccination practices and office-specific administrative processes 2. Design & implement a program for Ob/Gyns to vaccinate women against human papillomavirus, influenza, & pertussis 3. Determine the effectiveness of the vaccination program based on

* Pre- and post-program vaccination rates * Program satisfaction amongst Ob/Gyn providers and office staff * Willingness to continue and possibly extend the program to additional vaccines 4. Quantify the level of support and resources needed to develop and implement the vaccination program

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 4-5 community Ob/Gyn practices

Treatment and study plan

Vaccination Program

Other

Design & implement a program for Ob/Gyns to vaccinate women against human papillomavirus, influenza, & pertussis

Primary outcomes

  1. Implementation and measurement of a health services intervention in community or private Ob/Gyn practices to improve the delivery of standard clinical care to vaccinate women against human papillomavirus, influenza, & pertussis.

    Time frame: Full-scale program implementation will cover a 12 month period, tentatively planned to begin in April 2009.

Sponsors and collaborators

Lead sponsor

Duke University

Other

Collaborators

  • Centers for Disease Control and Prevention

Registry information

Important dates

Study start
2008
Primary completion
2009
Study completion
2012
First posted
Jan 26, 2009
Registry last updated
Oct 16, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.